FDA approves Amneal formulation of prednisolone acetate ophthalmic solution 1%

Published on June 12, 2025
The generic formulation references Pred Forte, which is trademarked by Allergan.
Continue reading on website
Other news

EyeCare Partners releases Quality and Outcomes Report, highlights optometric successes

June 12, 2025
The report highlights clinical successes, innovation, research, and patient outcomes.

Beacon Therapeutics Appoints Dr. Daniel Chung as Chief Medical Officer

June 13, 2025
LONDON and CAMBRIDGE, Mass.—Beacon Therapeutics Holdings Limited, a clinical-stage biotechnology company with a mission to save and restore the vision of patients with blinding retinal diseases, has announced the appointment of Dr. Daniel Chung as chief medical officer, effective immediately. According to the announcement, Dr. Chung brings a wealth of experience in clinical ophthalmology, academic